- Home
- TXN vs ABT Comparison
TXN vs ABT Comparison
Compare TXN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXN | ABT |
|---|---|---|
| Founded | 1930 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.9B | 189.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TXN | ABT |
|---|---|---|
| Price | $223.57 | $112.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 18 |
| Target Price | ★ $216.04 | $141.00 |
| AVG Volume (30 Days) | 10.0M | ★ 14.2M |
| Earning Date | 01-27-2026 | 01-22-2026 |
| Dividend Yield | ★ 2.51% | 2.22% |
| EPS Growth | ★ 4.81 | N/A |
| EPS | ★ 5.45 | 3.72 |
| Revenue | $17,682,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $11.45 | $8.92 |
| Revenue Next Year | $10.05 | $7.39 |
| P/E Ratio | $41.57 | ★ $30.53 |
| Revenue Growth | ★ 13.05 | 5.67 |
| 52 Week Low | $139.95 | $105.27 |
| 52 Week High | $231.32 | $141.23 |
Technical Indicators
Market Signals| Indicator | TXN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 41.72 |
| Support Level | $216.13 | $106.25 |
| Resistance Level | $231.32 | $111.00 |
| Average True Range (ATR) | 6.89 | 2.41 |
| MACD | 0.22 | 0.81 |
| Stochastic Oscillator | 79.85 | 73.38 |
Price Performance
Historical ComparisonAbout TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.